Indeed, several groups investigated the role of PSMA-PET imaging for the initial staging of CRCC, reporting its usefulness in the assessment of distant metastases, which showed unclear findings for conventional imaging [41,43,45,46]. This evidence concerns the gene FOLH1 and chromophobe renal cell carcinoma.